216 related articles for article (PubMed ID: 33234223)
1. Clinical Outcomes after Biologic Graft Use for the Creation of Blalock-Taussig Shunt in Critically Ill Patients with Thrombophilia.
Azboy D; Temiztürk Z
Heart Surg Forum; 2020 Oct; 23(6):E718-E724. PubMed ID: 33234223
[TBL] [Abstract][Full Text] [Related]
2. Bovine mesenteric venous graft as an alternative conduit in patients with cyanotic heart disease with e-polytetrafluoroethylene graft failure caused by thrombophilic factor positivity after modified Blalock-Taussig shunt.
Akbulut B; Dogan OF; Guvener M; Yilmaz M; Yorgancioglu C; Karagoz T; Ozkutlu S; Demircin M; Dogan R
Heart Surg Forum; 2008; 11(1):E37-41. PubMed ID: 18270138
[TBL] [Abstract][Full Text] [Related]
3. Cryopreserved Saphenous Vein Compared With PTFE Graft for Use as Modified Blalock-Taussig or Central Shunt in Cyanotic Congenital Heart Disease.
Kaur R; Bhurtel D; Bielefeld MR; Morales JM; Durham LA
World J Pediatr Congenit Heart Surg; 2018 Sep; 9(5):509-512. PubMed ID: 30157727
[TBL] [Abstract][Full Text] [Related]
4. Emergency transcatheter balloon recanalization of acutely thrombosed modified Blalock-Taussig shunts.
Sivakumar K; Anil SR; Ravichandra M; Natarajan KU; Kamath P; Kumar RK
Indian Heart J; 2001; 53(6):743-8. PubMed ID: 11838928
[TBL] [Abstract][Full Text] [Related]
5. High acetylsalicylic acid dosing in infants after modified Blalock-Taussig shunt.
Saini A; Joshi AD; Cowan KM; Wayne Gatewood C; Kumar STK; Allen J; Shah SH; Nouer SS; Jones T; Knott-Craig CJ; Boston US
Cardiol Young; 2019 Mar; 29(3):389-397. PubMed ID: 30739623
[TBL] [Abstract][Full Text] [Related]
6. Modified Blalock Taussig shunt: a not-so-simple palliative procedure.
Dirks V; Prêtre R; Knirsch W; Valsangiacomo Buechel ER; Seifert B; Schweiger M; Hübler M; Dave H
Eur J Cardiothorac Surg; 2013 Dec; 44(6):1096-102. PubMed ID: 23539419
[TBL] [Abstract][Full Text] [Related]
7. Systemic-to-pulmonary artery shunting using heparin-bonded grafts.
Ambarsari YA; Purbojo A; Blumauer R; Glöckler M; Toka O; Cesnjevar RA; Rüffer A
Interact Cardiovasc Thorac Surg; 2018 Oct; 27(4):591-597. PubMed ID: 29635442
[TBL] [Abstract][Full Text] [Related]
8. Modified Blalock-Taussig Shunt: A Single-Center Experience and Follow-Up.
Li D; Wang Y; Lin K; An Q
Heart Surg Forum; 2020 Feb; 23(1):E053-E057. PubMed ID: 32118543
[TBL] [Abstract][Full Text] [Related]
9. Perigraft seroma complicating the modified Blalock-Taussig shunts: two consecutive instances with review of literature.
Demircin M; Doğan R; Ozkan M; Ozsoy F; Kuzgun E; Güvener M
Turk J Pediatr; 2004; 46(3):275-8. PubMed ID: 15503486
[TBL] [Abstract][Full Text] [Related]
10. Optimal Graft Size of Modified Blalock-Taussig Shunt for Biventricular Circulation in Neonates and Small Infants.
Shibata M; Itatani K; Oka N; Yoshii T; Nakamura Y; Kitamura T; Horai T; Miyaji K
Int Heart J; 2015; 56(5):533-6. PubMed ID: 26370364
[TBL] [Abstract][Full Text] [Related]
11. Sternotomy approach for modified Blalock-Taussig shunt: is it a safe option?
Kandakure PR; Dharmapuram AK; Ramadoss N; Babu V; Rao IM; Murthy KS
Asian Cardiovasc Thorac Ann; 2010 Aug; 18(4):368-72. PubMed ID: 20719789
[TBL] [Abstract][Full Text] [Related]
12. Clinical results of combined palliative procedures for cyanotic congenital heart defects with intractable hypoplasia of pulmonary arteries.
Fan XM; Zhu YB; Su JW; Zhang J; Li ZQ; Xu YQ; Li XF; Liu YL
Chin Med J (Engl); 2013; 126(9):1678-82. PubMed ID: 23652050
[TBL] [Abstract][Full Text] [Related]
13. Modified Blalock-Taussig shunt: immediate and short-term follow-up results in neonates.
Ahmad U; Fatimi SH; Naqvi I; Atiq M; Moizuddin SS; Sheikh KB; Shahbuddin S; Naseem TM; Javed MA
Heart Lung Circ; 2008 Feb; 17(1):54-8. PubMed ID: 17683985
[TBL] [Abstract][Full Text] [Related]
14. Development of a perigraft seroma around modified Blalock-Taussig shunts: imaging evaluation.
van Rijn RR; Berger RM; Lequin MH; Robben SG
AJR Am J Roentgenol; 2002 Mar; 178(3):629-33. PubMed ID: 11856688
[TBL] [Abstract][Full Text] [Related]
15. Effects of hemodilution on outcome after modified Blalock-Taussig shunt operation in children with cyanotic congenital heart disease.
Sahoo TK; Chauhan S; Sahu M; Bisoi A; Kiran U
J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):179-83. PubMed ID: 17418728
[TBL] [Abstract][Full Text] [Related]
16. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.
Wu O; Robertson L; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Langhorne P; Brenkel I; Regan L; Greer I
Health Technol Assess; 2006 Apr; 10(11):1-110. PubMed ID: 16595080
[TBL] [Abstract][Full Text] [Related]
17. Classic Blalock-Taussig shunt in neonates.
Yoshimura N; Yamaguchi M; Ohashi H; Oshima Y; Toyoda Y; Ogawa K
J Cardiovasc Surg (Torino); 1999 Feb; 40(1):107-10. PubMed ID: 10221395
[TBL] [Abstract][Full Text] [Related]
18. Post Blalock-Taussig shunt mediastinal mass - a single shadow with two different destinies.
Rohit MK; Vadivelu R; Khandelwal N; Krishna S
Indian Heart J; 2014; 66(2):227-30. PubMed ID: 24814123
[TBL] [Abstract][Full Text] [Related]
19. A comparison of Blalock-Taussig, Waterston, and polytetrafluoroethylene shunts in children less than two weeks of age.
Woolf PK; Stephenson LW; Meijboom E; Bavinck JH; Gardner TJ; Donahoo JS; Edie RN; Edmunds LH
Ann Thorac Surg; 1984 Jul; 38(1):26-30. PubMed ID: 6203495
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter Treatment of Thrombosis in the Single Ventricle Pathway: An Institutional Experience.
Diab YA; Ramakrishnan K; Alfares FA; Hynes CF; Chounoune R; Shankar V; Kanter JP; Nath DS
Congenit Heart Dis; 2016; 11(1):39-44. PubMed ID: 26477998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
